Cataract surgery in Australia: a review of the regional literature and outcomes from 5018 cases at a tertiary teaching hospital.

Abstract

Objectives: To report visual and surgical outcomes of phacoemulsification cataract surgery from 5018 consecutive cases from Sydney, Australia. A review of the Australian and New Zealand literature was undertaken to provide a benchmark of outcomes from the region.

Methods: The electronic medical record system was used to review three time-points for all phacoemulsification cataract surgeries at a tertiary-referral centre between May 2017 and August 2020: preoperative, intraoperative and one month postoperatively. Variables collected included uncorrected distance visual acuity (UDVA) and pinhole visual acuity, surgeon seniority and ocular pathology.

Results: Of the 5018 eyes, 37.3% were operated on by consultants, 47.1% by trainees and 15.6% by fellows. Ocular pathology was seen in 48.9% of eyes (n=1709). The mean preoperative and one month postoperative UDVA was 6/48 and 6/12, respectively. There was an intraoperative complication in 7.6% of eyes (n=379) and posterior capsular rupture (PCR) occurred in 2.7% (n=136). PCR rates between consultants (3.1%, n=56), trainees (2.6%, n=61) and fellows (2.1%, n=16) showed no statistically significant difference (p≥0.355). The key risk factors for PCR were advanced cataract, alpha-antagonist use, small pupil size and the presence of glaucoma.

Conclusion: We present visual and surgical outcomes from the largest study on phacoemulsification cataract surgery in Australia and New Zealand, acknowledging the study's retrospective nature preventing inter-eye correlations, subdivision of cataract subspecialist versus not and trainee rank, and the minority of missing data. Our findings were comparable to regional and international benchmarks despite a high rate of ocular pathology and trainee case load. The lack of a regional cataract surgery registry represents a critical need in assessing and claiming key performance indicators, capturing emerging trends and identifying region-specific risk factors to deliver the best patient outcomes.